Anti-septic effects of dabrafenib on HMGB1-mediated inflammatory responses

A nucleosomal protein, high mobility group box 1 (HMGB1) is known to be a late mediator of sepsis. Dabrafenib is a B-Raf inhibitor and initially used for the treatment of metastatic melanoma therapy. Inhibition of HMGB1 and renewal of vascular integrity is appearing as an engaging therapeutic strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Byeongjin, Kang, Hyejin, Lee, Wonhwa, Noh, Hyun Jin, Kim, You-Sun, Han, Min-Su, Baek, Moon-Chang, Kim, Jaehong, Bae, Jong-Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2016
Materias:
Research-Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915240/
https://www.ncbi.nlm.nih.gov/pubmed/26592934
http://dx.doi.org/10.5483/BMBRep.2016.49.4.220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915240/
https://www.ncbi.nlm.nih.gov/pubmed/26592934
http://dx.doi.org/10.5483/BMBRep.2016.49.4.220

Ejemplares similares